[Form 4] BARK, Inc. Insider Trading Activity
Matt Meeker, Executive Chairman and Director of Bark, Inc. (BARK), was granted 1,357,689 restricted stock units (RSUs) on 08/20/2025. Each RSU represents the contingent right to receive one share of common stock and vests quarterly in substantially equal amounts over three years from the vesting commencement date of 08/20/2025, subject to his continuous service at each vesting date and acceleration upon certain events. After the award, the filing reports Mr. Meeker beneficially owns 12,127,083 shares. The grant was reported on a Form 4 filed and signed by an attorney-in-fact on 08/22/2025.
- Significant equity alignment: Grant of 1,357,689 RSUs increases Mr. Meeker's ownership to 12,127,083 shares, aligning executive incentives with shareholders.
- Long-term vesting schedule: RSUs vest quarterly over three years, promoting retention and continued service.
- None.
Insights
TL;DR: Executive equity award aligns leadership incentives with shareholders via sizable RSU grant vesting over three years.
The RSU grant of 1,357,689 units is a meaningful equity allocation for an executive and increases reported beneficial ownership to 12,127,083 shares, reinforcing a stake in the company nd aligning long-term interests with shareholders through quarterly vesting over three years. The award carries standard service-based vesting and acceleration upon specified events; the filing does not disclose the triggering events or potential accounting impact. No cash consideration was paid per the filing.
TL;DR: Grant follows common governance practice but disclosure lacks detail on acceleration triggers and performance conditions.
The disclosure shows time-based RSUs vesting quarterly over three years, which is typical for retention and alignment. The Form 4 confirms service-based vesting and unspecified acceleration events but does not describe performance metrics, clawbacks, or specific acceleration conditions. The filing is complete for Section 16 reporting but limited in contractual detail, which may require review of the related equity award agreement or proxy disclosures for full governance assessment.